Northern Trust’s PAVmed PAVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-3,576
| Closed | -$23.7K | – | 4498 |
|
|
2025
Q4 | $23.7K | Buy |
3,576
+2,026
| +131% | +$23.1K | ﹤0.01% | 4378 |
|
|
2025
Q3 | $20K | Buy |
1,550
+1,160
| +297% | +$17.2K | ﹤0.01% | 4374 |
|
|
2025
Q2 | $7.03K | Hold |
390
| – | – | ﹤0.01% | 4382 |
|
|
2025
Q1 | $8.45K | Hold |
390
| – | – | ﹤0.01% | 4398 |
|
|
2024
Q4 | $7.35K | Hold |
390
| – | – | ﹤0.01% | 4432 |
|
|
2024
Q3 | $14.4K | Hold |
390
| – | – | ﹤0.01% | 4358 |
|
|
2024
Q2 | $9.54K | Sell |
390
-2
| -0.5% | -$100 | ﹤0.01% | 4385 |
|
|
2024
Q1 | $25.1K | Sell |
392
-40
| -9% | -$3.02K | ﹤0.01% | 4314 |
|
|
2023
Q4 | $53.4K | Buy |
432
+124
| +40% | +$14.6K | ﹤0.01% | 4230 |
|
|
2023
Q3 | $40.9K | Sell |
308
-29
| -9% | -$4.5K | ﹤0.01% | 4216 |
|
|
2023
Q2 | $61.8K | Hold |
337
| – | – | ﹤0.01% | 4163 |
|
|
2023
Q1 | $56.6K | Buy |
337
+40
| +13% | +$8.42K | ﹤0.01% | 4234 |
|
|
2022
Q4 | $64.2K | Sell |
297
-1
| -0.3% | -$378 | ﹤0.01% | 4219 |
|
|
2022
Q3 | $116K | Sell |
298
-38
| -11% | -$21.5K | ﹤0.01% | 4067 |
|
|
2022
Q2 | $141K | Sell |
336
-1,085
| -76% | -$524K | ﹤0.01% | 4051 |
|
|
2022
Q1 | $844K | Sell |
1,421
-66
| -4% | -$49K | ﹤0.01% | 3509 |
|
|
2021
Q4 | $1.65M | Sell |
1,487
-9
| -0.6% | -$19.6K | ﹤0.01% | 3319 |
|
|
2021
Q3 | $5.75M | Sell |
1,496
-100
| -6% | -$315K | ﹤0.01% | 2641 |
|
|
2021
Q2 | $4.6M | Buy |
1,596
+112
| +8% | +$265K | ﹤0.01% | 2892 |
|
|
2021
Q1 | $2.96M | Buy |
1,484
+594
| +67% | +$893K | ﹤0.01% | 3042 |
|
|
2020
Q4 | $849K | Sell |
890
-37
| -4% | -$31.6K | ﹤0.01% | 3576 |
|
|
2020
Q3 | $743K | Buy |
927
+642
| +225% | +$571K | ﹤0.01% | 3506 |
|
|
2020
Q2 | $271K | Buy |
285
+180
| +171% | +$180K | ﹤0.01% | 3689 |
|
|
2020
Q1 | $93K | Buy |
105
+56
| +114% | +$45.8K | ﹤0.01% | 3829 |
|
|
2019
Q4 | $27K | Hold |
49
| – | – | ﹤0.01% | 4123 |
|
|
2019
Q3 | $21K | Hold |
49
| – | – | ﹤0.01% | 4146 |
|
|
2019
Q2 | $25K | Hold |
49
| – | – | ﹤0.01% | 4148 |
|
|
2019
Q1 | $24K | Hold |
49
| – | – | ﹤0.01% | 4115 |
|
|
2018
Q4 | $21K | Hold |
49
| – | – | ﹤0.01% | 4147 |
|
|
2018
Q3 | $29K | Buy |
+49
| New | +$29.9K | ﹤0.01% | 4190 |
|
Other funds holding PAVM
TSC
VCM
VFT
TRCT
Northern Trust's PAVM Position: Q1 2026 in Review
Northern Trust sold out of PAVmed (PAVM) in Q1 2026, closing a stake of 3,576 shares — an estimated $23.7K sold.
Northern Trust first reported a position in PAVM in Q3 2018 and held it in 30 quarters. The position peaked at $5.75M in Q3 2021. 20 funds tracked by Wall St. Rank hold PAVM as of Q1 2026.
- Northern Trust reported no remaining PAVmed position as of Q1 2026 after selling out during the quarter.
- Northern Trust sold 3,576 PAVmed shares in Q1 2026, an estimated $23.7K.
- Northern Trust first reported a position in PAVmed in Q3 2018 and held it in 30 quarters.
- Northern Trust's PAVmed position peaked at $5.75M in Q3 2021.
- 20 funds tracked by Wall St. Rank held PAVmed as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.